A Safety and Efficacy Study of JUVÉDERM® VOLIFT® With Lidocaine and Restylane® for Nasolabial Folds in Chinese Adults

Study Identifier
VOLIFT-002
CT.gov Identifier
NCT02558283
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Facial Aesthetics - Fillers
    • Study Drug
    N/A
    Phase
    N/A
    Sex
    Female & Male
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Presence of nasolabial folds * Agree to refrain from treatment with other anti-wrinkle/volumizers below the eye for the duration of the study
    Exclusion Criteria:
    * Ever received semi-permanent fillers or permanent facial implants below the eyes, or plans to receive these treatments during the study * Undergone temporary dermal filler treatment (eg, hyaluronic acid or collagen) below the eyes within 12 months, or plans to undergo these treatments during the study * Undergone facial tissue augmentation with fat injections, botulinum toxin injections, mesotherapy, or cosmetic facial procedures in the face or neck within 6 months, or plans to undergo these treatments during the study

    Protocol Summary

    This is a safety and efficacy study of JUVÉDERM® VOLIFT® with Lidocaine and Restylane® in Chinese adults with nasolabial folds.

    Study Locations

    Location
    Status
    Location
    China Japan Friendship Hospital
    Beijing, China
    Status
    Not applicable
    Location
    Peking University Third Hospital
    Beijing, China
    Status
    Not applicable
    Location
    General Hospital of Guangzhou Military Command of PLA
    Guangzhou, China
    Status
    Not applicable
    Location
    Union Hospital Tongji Medical College Huazhong University of Science and Technology
    Guangzhou, China
    Status
    Not applicable
    Location
    Shanghai 9th Hospital
    Shanghai, China
    Status
    Not applicable